Kaiser Pemanente Offers Free Training to Bilingual Healthcare Workers; FDA Approves New IBS Drug; New Study Says Chocolate Lowers Men's Stroke Risk

Hello, I’m Francesca DeRogatis and these are your 3BL Health Headlines:

Kaiser Permanente has hosted 14 nonprofit health care organizations at its Atlanta headquarters for its Qualified Bilingual Staff training. The five-day program, offered at no charge, provides specialized education to bilingual employees to support their linguistic skills with the goal of improving the overall patient care experience.

The FDA has approved Linzess, a new drug that improves many of the symptoms of irritable bowel syndrome with few side effects. In trials, the drug began working within the first few days of treatment to relieve pain and other symptoms. Ironwood Pharmaceuticals, the manufacturer of Linzess, says the drug will be available by the end of the year.

A man’s risk of stroke can be lowered by 17 percent by eating one chocolate bar every week, according to a new study. The report, from the Karolinska Institute in Sweden, suggested that eating more chocolate could reduce risks even further. 37,000 Swedish men aged 49 to 75 participated in the study.

For more news and information, go to 3blmedia.com.

Episode Sources: